Cell Biochemistry and Function · 2004 · 34 citations · 22 references
Life SciencesGeneticsOncologyApoptosisCancer GeneticsMolecular OncologyApoptosis In CancerMalignant NeoplasmsMetastatic Breast CancerTumor Suppressor GenesApoptosis Signaling In CancerBreast Cancer Molecular SubtypesGenetic Drift EffectsGenetic InstabilityMetastatic Breast Cancer BiologyTumor Suppressor Gene AnalysisTumor Suppressor PathwaysWestern Blot Analysis
The MCF-7 human breast carcinoma cell line is widely used as a model system by breast cancer researchers and cell biologists investigating apoptosis. Since its establishment 30 years ago, from a patient with metastatic breast cancer, the original MCF-7 cell population has undergone genetic drift to such an extent that numerous genetically diverse sublines now exist. For instance, it has been reported that MCF-7 cells have lost the region 3p21.3, to which the apoptosis regulatory protein and putative tumour suppressor LUCA-15 (also called RBM5 and H37) maps; however, LUCA-15 has been cloned from MCF-7 cells, and LUCA-15 expression analyses have been conducted using MCF-7 cells. To address this discrepancy, we characterized three MCF-7 sublines by Western blot, RT-PCR and finally genomic PCR analysis, and determined that one of the three had lost the LUCA-15 gene. Interestingly, loss of LUCA-15 was positively correlated with decreased susceptibility to the death-inducing ligand TNF-alpha. Subsequent overexpression of exogenous LUCA-15 was shown to enhance TNF-alpha-mediated apoptosis, suggesting that LUCA-15 may play a role in regulating the susceptibility of breast cancer cells to drug-induced apoptosis. These results not only reinforce the necessity of MCF-7 subline characterization, but provide the first evidence of an apoptotic modulatory role for LUCA-15 in a non-T cell line.
22
A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
Herbert D. Soule, J. Vázquez, Anna Long et al. · JNCI Journal of the National Cancer Institute · 1973 · 2.5K citations
Medicine, Cell Biology, Oncology +10